Treatment Registry
TR-0691 ActiveRecorded September 2026Last verified October 2026

Compounded tirzepatide

Sold by iThriveMD · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

TermPublished rateCharged today
First 28-day cycleIntroductory

“$299”

$299Per 28 daysCharged today$299
Following 28-day cycles

“$399”

$399Per 28 daysCharged today$399
12 weeks prepaid; advertised cycle equivalent

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$299.25”

$299.25Published figureCharged todayNot verified
24 weeks prepaid; advertised cycle equivalent

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$259.35”

$259.35Published figureCharged todayNot verified
48 weeks prepaid; advertised cycle equivalent

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$199.5”

$199.50Published figureCharged todayNot verified
Price sources
Visit iThriveMD

We earn nothing from this link. It opens iThriveMD's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesCalifornia and Arizona
PrescriberLive visit
MembershipNot disclosed
Consult feeNot disclosed

Not yet checked: cancellation.

Recorded from ithrivemd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Local clinics in Southern/Northern California and Arizona plus a 'Virtual appointments/Telehealth' option. /policy/terms-of-use/ and /weight-loss/ pages returned essentially empty visible-text bodies to this tool (heavily JS-rendered), so states-served, prescriber sync/async, and cancellation policy could not be verified despite checking. Microdosing Tirzepatide plan description: 'This price covers your first 30-minute consultation, monthly 15-minute follow-up visits, and up to 3 mg of tirzepatide each week.'
  2. 2. October 2026 — iThriveMD bills recurring treatment every 28 days, so there are more billing cycles than calendar months in a year. Its longer prepaid offers cover 12, 24 or 48 weeks; confirm the full amount due before purchase. The provider offers appointments in California and Arizona. The public returns page did not provide readable refund terms.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0691
Medication category
compounded tirzepatide
Readings
2

Related records

Cite this entry

Treatment Registry. (2026). iThriveMD — compounded tirzepatide (TR-0691). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0691

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.